0001209191-22-044132.txt : 20220803
0001209191-22-044132.hdr.sgml : 20220803
20220803152426
ACCESSION NUMBER: 0001209191-22-044132
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20220801
FILED AS OF DATE: 20220803
DATE AS OF CHANGE: 20220803
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Leaver Sharyn
CENTRAL INDEX KEY: 0001906010
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21433
FILM NUMBER: 221132287
MAIL ADDRESS:
STREET 1: C/O FORRESTER RESEARCH, INC.
STREET 2: 60 ACORN PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FORRESTER RESEARCH, INC.
CENTRAL INDEX KEY: 0001023313
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-ENGINEERING, ACCOUNTING, RESEARCH, MANAGEMENT [8700]
IRS NUMBER: 042797789
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 60 ACORN PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
BUSINESS PHONE: 6176136000
MAIL ADDRESS:
STREET 1: 60 ACORN PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
FORMER COMPANY:
FORMER CONFORMED NAME: FORRESTER RESEARCH INC
DATE OF NAME CHANGE: 19960919
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-08-01
0
0001023313
FORRESTER RESEARCH, INC.
FORR
0001906010
Leaver Sharyn
C/O FORRESTER RESEARCH, INC.
60 ACORN PARK DRIVE
CAMBRIDGE
MA
02140
0
1
0
0
Chief Research Officer
Common Stock
2022-08-01
4
M
0
2475
0.00
A
6683
D
Common Stock
2022-08-01
4
F
0
733
47.53
D
5950
D
Restricted Stock Units
0.00
2022-08-01
4
M
0
364
0.00
D
common stock
364
0
D
Restricted Stock Units
0.00
2022-08-01
4
M
0
589
0.00
D
common stock
589
589
D
Restricted Stock Units
0.00
2022-08-01
4
M
0
695
0.00
D
common stock
695
1388
D
Restricted Stock Units
0.00
2022-08-01
4
M
0
827
0.00
D
common stock
827
2478
D
Represents the conversion, upon vesting, of restricted stock units into common stock.
Represents shares withheld by the Issuer to satisfy tax withholding obligations upon the vesting on August 1, 2022 of the restricted stock units awarded to the reporting person on August 1, 2018, August 1, 2019, August 3, 2020 and August 2, 2021. The awards include a provision for the withholding of shares by the Issuer to satisfy withholding taxes due as a result of the vesting of the awards.
Each Restricted Stock Unit represents the right to receive, following vesting, one share of Forrester Research, Inc. common stock.
On August 1, 2018, the reporting person was granted 1458 Restricted Stock Units that vest and convert into common stock in four equal and consecutive installments beginning on the first anniversary of the grant date.
Each Restricted Stock Unit is the equivalent of one share of Forrester Research, Inc. common stock.
On August 1, 2019, the reporting person was granted 2358 Restricted Stock Units that vest and convert into common stock in four equal and consecutive installments beginning on the first anniversary of the grant date.
On August 3, 2020, the reporting person was granted 2778 Restricted Stock Units that vest and convert into common stock in four equal and consecutive installments on August 1, 2021, August 1, 2022, August 1, 2023 and August 1, 2024.
On August 2, 2021, the reporting person was granted 3305 Restricted Stock Units that vest and convert into common stock in four equal and consecutive installments on August 1, 2022, August 1, 2023, August 1, 2024 and AUgust 1, 2025.
Maite Garcia, attorney-in-fact for Sharyn Leaver
2022-08-03
EX-24
2
poa.txt
POA DOCUMENT
LIMITED POWER OF ATTORNEY
I hereby constitute and appoint each of Ryan Darrah, Maite Garcia, Jed
Rosenkrantz and Benedicta Agyemang signing singly, my true and lawful
attorney-in-fact to:
(1) execute for and on my behalf, in my capacity as an officer and/or director
of Forrester Research, Inc. (the "Company"), Forms 3, 4 and 5 in accordance with
Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;
(2) do and perform any and all acts for and on my behalf that may be necessary
or desirable to complete and execute any such Form 3, 4 or 5 and timely file
such form with the United States Securities and Exchange Commission and any
stock exchange or similar authority; and
(3) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be to my benefit,
in my best interest, or that I am legally required to do, it being understood
that the documents executed by such attorney-in-fact on my behalf pursuant to
this Power of Attorney shall be in such form and shall contain such terms and
conditions as such attorney-in-fact may approve in such attorney-in-fact's
discretion.
I hereby grant to such attorney-in-fact full power and authority to do and
perform any and every act and thing whatsoever requisite, necessary, or proper
to be done in the exercise of any of the rights and powers herein granted, as
fully to all intents and purposes as I might or could do if personally present,
with full power of substitution or revocation, hereby ratifying and confirming
all that such attorney-in-fact, or such attorney-in-fact's substitute or
substitutes, shall lawfully do or cause to be done by virtue of this power of
attorney and the rights and powers herein granted. I acknowledge that the
attorney-in-fact, in serving in such capacity at my request, are not assuming,
nor is the Company assuming, any of my responsibilities to comply with Section
16 of the Securities Exchange Act of 1934.
This Power of Attorney shall remain in full force and effect until I am no
longer required to file Forms 3, 4 and 5 with respect to my holdings of and
transactions in Company securities, unless I earlier revoke it in a signed
writing delivered to the attorneys-in-fact. Upon signature of this Power of
Attorney, I hereby revoke all previous powers of attorney granted concerning the
subject matter herein.
IN WITNESS WHEREOF, I have caused this Power of Attorney to be executed as of
this 13th day of January, 2022.
/s/ Sharyn Leaver
Signature
Sharyn Leaver
Print Name